AIM Vaccine Co., Ltd. (HKG:6660)

AIM Vaccine Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	494.27	583.14	635.18	646.74	1,103
Short-Term Investments	100.61	153.27	183.74	-	-
Trading Asset Securities	-	-	-	100	-
Cash & Short-Term Investments	594.87	736.42	818.91	746.74	1,103
Cash Growth	-19.22%	-10.07%	9.66%	-32.29%	199.16%
Accounts Receivable	1,124	1,005	1,053	1,064	869.86
Other Receivables	44.5	57.33	5.95	15.82	81.09
Receivables	1,168	1,062	1,059	1,079	950.95
Inventory	462.61	509.86	504.74	367.4	252.71
Restricted Cash	47.59	42.24	11.17	22.32	24.41
Other Current Assets	114.07	132.02	155.34	142.75	107.56
Total Current Assets	2,387	2,483	2,549	2,359	2,438
Property, Plant & Equipment	3,479	3,522	3,488	2,871	1,527
Goodwill	271.45	271.45	482.9	482.9	234.57
Other Intangible Assets	268.81	288.63	305.94	311.73	343.59
Long-Term Deferred Tax Assets	109.97	95.33	-	-	1.46
Long-Term Deferred Charges	720.55	516.78	1,933	1,881	13.27
Other Long-Term Assets	76.72	85.34	117.6	167.48	129.17
Total Assets	7,314	7,262	8,876	8,072	4,688
Accounts Payable	50.89	60.36	73.58	51.76	37.97
Accrued Expenses	1,003	680.92	564.33	505.92	451.79
Short-Term Debt	1,122	1,151	966.61	397.39	123.82
Current Portion of Long-Term Debt	271.32	54.27	44.08	9.98	50.05
Current Portion of Leases	13.96	20.54	19.34	16.9	14.63
Current Income Taxes Payable	3.47	2.89	7.87	40.89	51.12
Current Unearned Revenue	41.31	63.04	62.02	45.65	18.45
Other Current Liabilities	583.63	568.45	511.96	501.56	383.12
Total Current Liabilities	3,090	2,602	2,250	1,570	1,131
Long-Term Debt	424.99	556.94	339.44	184.33	-
Long-Term Leases	8.54	12.43	29.19	41.83	46.69
Long-Term Unearned Revenue	154.42	159.99	127.44	85.03	51.66
Long-Term Deferred Tax Liabilities	25	41.16	269.01	491.83	37.01
Total Liabilities	3,703	3,372	3,015	2,373	1,266
Common Stock	1,211	1,211	1,211	1,200	1,110
Retained Earnings	-1,911	-1,634	-332.68	-13.08	679.7
Comprehensive Income & Other	4,065	4,065	4,082	3,706	1,632
Total Common Equity	3,366	3,643	4,960	4,893	3,422
Minority Interest	245.59	246.82	900.67	806.7	-
Shareholders' Equity	3,611	3,890	5,861	5,699	3,422
Total Liabilities & Equity	7,314	7,262	8,876	8,072	4,688
Total Debt	1,841	1,796	1,399	650.43	235.19
Net Cash (Debt)	-1,246	-1,059	-579.76	96.31	867.64
Net Cash Growth	-	-	-	-88.90%	-
Net Cash Per Share	-1.03	-0.87	-0.48	0.08	0.90
Filing Date Shares Outstanding	1,211	1,211	1,211	1,200	962.57
Total Common Shares Outstanding	1,211	1,211	1,211	1,200	962.57
Working Capital	-702.87	-118.96	298.91	788.64	1,307
Book Value Per Share	2.78	3.01	4.10	4.08	3.55
Tangible Book Value	2,825	3,083	4,171	4,098	2,843
Tangible Book Value Per Share	2.33	2.55	3.44	3.41	2.95
Buildings	1,035	1,024	806.39	682.19	534.02
Machinery	637.8	654.19	613.79	532.28	437.86
Construction In Progress	2,356	2,259	2,378	1,884	711.57
Leasehold Improvements	85.94	83.47	107.78	70.71	63.6

Updated Aug 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.